Sanford Hillsberg Insider Trading $SLS SELLAS Life Sciences Group, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Sanford Hillsberg.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Sanford Hillsberg. Sanford Hillsberg is 10% Owner in Cordex Pharma, Inc. ($DSKT) and Secretary in Cordex Pharma, Inc. ($DSKT) and Director in Galena Biopharma, Inc. ($GALE) and Director in Lion Biotechnologies, Inc. ($LBIO).

Sanford Hillsberg in SELLAS Life Sciences Group, Inc.

Trading Symbol: SLS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sanford Hillsberg: Director
Holdings: 95,447 shares
Current Value: $133,626
Latest Transaction: Jan 31 2014
$SLS Market Capitalization: $9.04M
$SLS Previous Close: $1.40

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Sanford Hillsberg in SELLAS Life Sciences Group, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, DSKT, IOVA, SLS

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jan 31 2014	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Option Exercise	H	1.71	50,000	85,500	0
Jan 31 2014	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Option Exercise	M	1.18	100,000	118,000	0
Jan 31 2014	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Option Exercise	M	1.18	100,000	118,000	0
Jan 31 2014	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Gift	G	0.00	15,000	0	95,447	110.4 K to 95.4 K (-13.58 %)
Jan 31 2014	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Sell	S	5.41	250,000	1,352,500	17,974	268 K to 18 K (-93.29 %)
Jan 31 2014	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Buy	M	1.71	50,000	85,500	267,974	218 K to 268 K (+22.94 %)
Jan 31 2014	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Buy	M	1.18	200,000	236,000	217,974	18 K to 218 K (+1,112.72 %)
Jan 22 2014	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Sell	S	6.93	200,000	1,385,000	110,447	310.4 K to 110.4 K (-64.42 %)
Jan 16 2014	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Option Exercise	M	0.85	200,000	170,000	0
Jan 16 2014	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Payment of Exercise	F	6.96	24,426	170,005	310,447	334.9 K to 310.4 K (-7.29 %)
Jan 16 2014	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Buy	M	0.85	200,000	170,000	334,873	134.9 K to 334.9 K (+148.29 %)
Dec 13 2013	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Option Exercise	M	0.72	50,000	36,000	0
Dec 13 2013	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Payment of Exercise	F	4.19	8,592	36,000	134,873	143.5 K to 134.9 K (-5.99 %)
Dec 13 2013	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Buy	M	0.72	50,000	36,000	143,375	93.4 K to 143.4 K (+53.55 %)
Dec 13 2013	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Gift	G	0.00	37,001	0	93,375	130.4 K to 93.4 K (-28.38 %)
Nov 27 2013	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Option Exercise	A	3.88	200,000	776,000	200,000
Oct 15 2013	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Grant	A	0.00	2,630	0	17,974	15.3 K to 18 K (+17.14 %)
Jun 13 2013	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Grant	A	0.00	9,327	0	145,703	136.4 K to 145.7 K (+6.84 %)
Jul 10 2012	GALE	Galena Biopharma, ...	Hillsberg Sanford	Director	Grant	A	0.00	31,966	0	156,376	124.4 K to 156.4 K (+25.69 %)

Page: 1